534TiPA randomized phase III study of carboplatin plus nab-paclitaxel with or without nintedanib for NSCLC with IPF (J-SONIC).

Autor:	Otsubo, K1 (AUTHOR), Kishimoto, J2 (AUTHOR), Kenmotsu, H3 (AUTHOR), Minegishi, Y4 (AUTHOR), Horinouchi, H5 (AUTHOR), Kato, T6 (AUTHOR), Ichihara, E7 (AUTHOR), Shiraki, A8 (AUTHOR), Atagi, S9 (AUTHOR), Ando, M10 (AUTHOR), Yamamoto, N11 (AUTHOR), Okamoto, I12 (AUTHOR)
Zdroj:	Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu